Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




World Record for Number of Tests Achieved in Single DNA Sequencing Analysis

By LabMedica International staff writers
Posted on 24 Mar 2011
Up to now, researchers have been limited to running just a few DNA samples at a time, at a cost of about US$16,000 per run. More...
Swedish researchers have devised a new method that allows 5,000 samples to be run at the same time and at the same price. This cuts the cost per sample result considerably and constitutes a world record for the number of tests run in a single DNA sequencing analysis.

"We were virtually forced to invent a method for running numerous DNA tests at once. Otherwise our analyses would have taken an incredibly long time and would have cost enormous sums of money,” said Dr. Peter Savolainen, a researcher in biology at the Royal Institute of Technology (KTH; Stockholm). He, his research colleague Dr. Afshin Ahmadian, and the then doctoral candidate Mårten Neiman jointly developed the new technique, which means that DNA sequencing analyses can be performed both in record time and at a remarkably low cost.

"Today the great majority of samples are run 10 at a time. This yields a cost of SEK 10,000 [about US$1,600] per sample. We have run 5,000 samples at the same time at the same cost, that is, SEK 100,000. This computes to SEK 20 per sample,” noted Dr. Savolainen. He pointed out several areas where his and his colleagues' new technology can have a great impact. One of them is cancer research; where there is a great need to scan numerous cell samples from many individuals.

"Another field where our method can be of huge importance is in organ transplants. Many DNA analyses are needed to create a database for matching organ donors with transplant recipients. This will be of major importance to DNA research,” stated Dr. Savolainen. He added that now, even before the method is validated, there are several projects at the Science for Life Laboratory (where KTH is involved) in line to use this mode of analysis. Moreover, it is possible to scale up the method so that even more samples can be tested simultaneously. "Simply put, we mark each sample in an ingenious way with an ID, so each test result can be distinguished,” concluded Dr. Savolainen.

Related Links:

Royal Institute of Technology





Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.